The study is designed to evaluate and compare the efficacy and cost effectiveness of 3 smoking cessation treatments with HIV-positive cigarette smokers. The treatments include face-to-face individual counseling, a computer-Internet-based self-help treatment and a self-help manual treatment.

All participants have access to an Internet-based self-help intervention that includes social support through message boards. All participants have access to 10 weeks of nicotine replacement treatment.

Experimental: Counseling

Individual counseling plus nicotine replacement treatment.

Behavioral: Individual Counseling

Six individual counseling sessions are provided over a 12 week treatment period. Participants also have access to a 10-week nicotine replacement treatment.

Active Comparator: Self-Help

Self-help Manual plus nicotine replacment treatment.

Behavioral: self-help

Participants receive a self-help manual and have access to a 10 nicotine replacement treatment.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00297453

Locations

United States, California

University of California, San Francisco

San Francisco, California, United States, 94143

Sponsors and Collaborators

University of California, San Francisco

National Institute on Drug Abuse (NIDA)

Investigators

Principal Investigator:

Gary Humfleet, Ph.D.

University of California, San Francisco

More Information

Responsible Party:

Gary Humfleet, Associate Professor, University of California, San Francisco